Financhill
Back

Pacific Biosciences of California Vs. Axogen Industry Stock Comparison

Sell
40

PACB
Pacific Biosciences of California

Last Price:
1.69
Seasonality Move:
-2.25%
Sell
27

AXGN
Axogen

Last Price:
6.55
Seasonality Move:
18.96%
Sell
40
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.69. The Score for PACB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Axogen (AXGN) is a Sell

Is Axogen a Buy, Sell or Hold?

  • The current Axogen [AXGN] share price is $6.56. The Score for AXGN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • AXGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight selling pressure.

AXGN Stock Price Chart

What is Axogen's stock price today?

  • The Axogen share price today is $6.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXGN is experiencing slight selling pressure.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 30.1 Sell
Chaikin Money Flow: -1876860 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.52 - 3.46) Sell
Bollinger Bands (100): (3.06 - 8.2) Sell

AXGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 35.97 Sell
Chaikin Money Flow: -29343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.66 - 7.8) Sell
Bollinger Bands (100): (7.01 - 9.53) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.52 Buy
20-day SMA: 2.22 Sell
50-day SMA: 3.47 Sell
200-day SMA: 7.57 Sell
8-day EMA: 1.64 Buy
20-day EMA: 2.14 Sell
50-day EMA: 3.4 Sell
200-day EMA: 6.71 Sell

AXGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.69 Sell
20-day SMA: 7.05 Sell
50-day SMA: 8.08 Sell
200-day SMA: 7.06 Sell
8-day EMA: 6.66 Sell
20-day EMA: 7.01 Sell
50-day EMA: 7.64 Sell
200-day EMA: 7.77 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.

Axogen Earnings Growth & AXGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.04 per share, an increase this year of $0.09 per share, and an increase next year of $0.32 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):